218 related articles for article (PubMed ID: 1473873)
1. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository.
Ellison NM; Lewis GO
Clin Pharm; 1984; 3(6):614-7. PubMed ID: 6548939
[TBL] [Abstract][Full Text] [Related]
3. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
[TBL] [Abstract][Full Text] [Related]
4. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
6. Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.
Matsumoto Y; Watanabe Y; Yamamoto I; Matsumoto M
Biol Pharm Bull; 1993 Feb; 16(2):150-3. PubMed ID: 8364450
[TBL] [Abstract][Full Text] [Related]
7. Availability of oxyphenbutazone from different suppository formulations.
Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of morphine in rabbits after rectal administration of suppository containing controlled release morphine tablet.
Kanamoto I; Zheng NX; Ueno M; Koizumi T; Adachi I; Horikoshi I
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1883-6. PubMed ID: 1394709
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of two novel rectal controlled-release morphine formulations.
Babul N; Darke AC; Anslow JA; Krishnamurthy TN
J Pain Symptom Manage; 1992 Oct; 7(7):400-5. PubMed ID: 1484193
[TBL] [Abstract][Full Text] [Related]
11. Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
Kawashima S; Inoue Y; Shimeno T; Fujiwara H
Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):498-505. PubMed ID: 2337965
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of controlled-release oral morphine sulfate during naltrexone blockade.
Bashaw ED; Kaiko RF; Grandy RP; Reder RF; Goldenheim PD
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):524-9. PubMed ID: 8520812
[TBL] [Abstract][Full Text] [Related]
13. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
14. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs].
Tan T; Kitamura K; Yamanaka M; Kojima K; Nakanishi Y; Arakawa S
Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of ibuprofen from oral and suppository preparations in rats.
Kaka JS; Tekle A
Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):171-82. PubMed ID: 1604043
[TBL] [Abstract][Full Text] [Related]
16. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
17. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
[TBL] [Abstract][Full Text] [Related]
18. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
Gourlay GK
Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories.
van Laar T; Jansen EN; Neef C; Danhof M; Roos RA
Mov Disord; 1995 Jul; 10(4):433-9. PubMed ID: 7565822
[TBL] [Abstract][Full Text] [Related]
20. Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer.
Nakamura K; Nara E; Akiyama Y
J Control Release; 2006 Apr; 111(3):309-15. PubMed ID: 16473430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
